(Q38235004)

31 August 2017

Henoch-Schönlein purpura nephritis in children (English)

1 reference

31 August 2017

Jean-Claude Davin

1

1 reference

31 August 2017

Rosanna Coppo

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

29 July 2014

1 reference

Nature Reviews Nephrology

31 August 2017

1 reference

31 August 2017

10

1 reference

31 August 2017

10

1 reference

31 August 2017

563-573

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2014.126

31 August 2017

0 references

cites work

Vasculitis in children

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch Schonlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

The American College of Rheumatology 1990 criteria for the classification of henoch-schönlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Long-term follow-up of childhood Henoch-Schönlein nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Clinical outcome of Schönlein-Henoch purpura nephritis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Prognosis of Henoch-Schönlein nephritis in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Hypertension as a late sequela of Henoch-Schönlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Predictors of outcome in Henoch-Schönlein nephritis in children and adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schönlein Purpura in adults: outcome and prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Localization of glomerular "deposits" in Henoch--Schönlein nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schönlein nephritis: a nationwide study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Histologic recurrence of Henoch-Schonlein Purpura nephropathy after renal transplantation on routine allograft biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Kidney transplantation in patients with IgA mesangial glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Risk of renal allograft loss from recurrent glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Polymorphs infiltrate glomeruli in mesangial IgA glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Grading of acute and chronic renal lesions in Henoch-Schönlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Glycosylation of IgA1 and pathogenesis of IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Disruption of Smad4 expression in T cells leads to IgA nephropathy-like manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Role of IgA and IgA fc receptors in inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Possible pathogenic role of IgE in Henoch-Schönlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Possible pathologenic role of interleukin-5 and eosino cationic protein in Henoch-Schönlein purpura nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Eosinophil cationic protein in Henoch-Schönlein purpura and in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

The pathophysiology of IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

The mesangial cell revisited: no cell is an island

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Complement 3 is involved in changing the phenotype of human glomerular mesangial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Glomerular Fc alphaR expression and disease activity in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Rapidly progressive crescentic glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Cell adhesion molecules and the glomerulopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

The ins and outs of glomerular crescent formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

IgA nephropathy: morphologic expression and pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Transforming growth factor beta in tissue fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schönlein purpura with hypocomplementemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Mesangial C4d deposition: a new prognostic factor in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Chapter 11: Henoch-Schönlein purpura nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Therapeutics. XV. The management of Henoch-Schonlein purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

31 March 2020

Anaphylactoid purpura

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Effective methylprednisolone dose in experimental crescentic glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Acute kidney injury: an increasing global concern

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Urinary excretion of complement C3d in patients with renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.126

THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS

31 March 2020

1 reference

12 December 2020

Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis

1 reference

12 December 2020

Modulators of crescentic glomerulonephritis.

1 reference

12 December 2020

Antibodies: basic mechanisms and emerging concepts.

1 reference

12 December 2020

Schönlein-Henoch nephritis

1 reference

12 December 2020

Long-term outcome of Schönlein-Henoch nephritis in the adult.

1 reference

12 December 2020

Urinary cross-linked fibrin degradation products in glomerular disease with crescents

1 reference

12 December 2020

Glomerular basement membrane discontinuities. Scanning electron microscopic study of acellular glomeruli

1 reference

12 December 2020

Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation.

1 reference

12 December 2020

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

1 reference

12 December 2020

Primary IgA nephropathies in children: prognosis and treatment.

1 reference

12 December 2020

Involvement of IL-6 in mesangial proliferative glomerulonephritis

1 reference

12 December 2020

The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis.

1 reference

12 December 2020

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

1 reference

12 December 2020

Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy

1 reference

12 December 2020

Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey.

1 reference

12 December 2020

Henoch-Schönlein nephritis: long-term prognosis of unselected patients

1 reference

12 December 2020

Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.

1 reference

12 December 2020

Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta

1 reference

12 December 2020

The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura

1 reference

12 December 2020

[Severe Schonlein-Henoch nephritis in adults. A report of twenty cases]

1 reference

12 December 2020

Berger disease: Henoch-Schönlein syndrome without the rash

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2014.126

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference